What is the recommended dosage of Septran (trimethoprim/sulfamethoxazole) for pediatric patients?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 4, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Septran (Trimethoprim-Sulfamethoxazole) Pediatric Dosing

For pediatric patients ≥2 months of age, the standard treatment dose is 8 mg/kg/day of trimethoprim (40 mg/kg/day of sulfamethoxazole) divided into two doses every 12 hours. 1, 2

Treatment Dosing by Indication

Urinary Tract Infections, Acute Otitis Media, and Shigellosis

  • Dose: 8 mg/kg trimethoprim + 40 mg/kg sulfamethoxazole per 24 hours, divided every 12 hours 1, 2
  • Duration: 10 days for UTI/otitis media; 5 days for shigellosis 1, 2
  • Weight-based dosing table (per dose every 12 hours): 1, 2
    • 10-20 kg: 1 single-strength tablet (80/400 mg)
    • 30 kg: 1½ single-strength tablets
    • 40 kg: 2 single-strength tablets OR 1 double-strength tablet

Skin and Soft Tissue Infections (including MRSA)

  • Dose: 8-12 mg/kg/day of trimethoprim divided every 12 hours 3
  • Duration: 7-10 days 3
  • The CDC recommends 5 mg/kg (trimethoprim component) every 12 hours as an alternative dosing approach 4

Pneumocystis jirovecii Pneumonia (PCP)

Treatment:

  • Dose: 15-20 mg/kg trimethoprim + 75-100 mg/kg sulfamethoxazole per 24 hours, divided every 6 hours 1, 2
  • Duration: 14-21 days 1, 2

Prophylaxis:

  • Dose: 150 mg/m²/day trimethoprim + 750 mg/m²/day sulfamethoxazole, divided every 12 hours 1, 2
  • Schedule: 3 consecutive days per week (alternative to daily dosing) 5
  • Maximum daily dose: 320 mg trimethoprim + 1600 mg sulfamethoxazole 1, 2
  • The CDC also recommends 8 mg/kg/day trimethoprim divided into two doses for prophylaxis 5

Critical Age Restriction

Septran is absolutely contraindicated in infants <2 months of age due to risk of kernicterus. 3, 1, 2

Renal Dose Adjustment

For patients with impaired renal function: 1, 2

  • CrCl >30 mL/min: Standard dosing
  • CrCl 15-30 mL/min: Reduce dose by 50%
  • CrCl <15 mL/min: Avoid use

Monitoring Requirements

  • Baseline: Complete blood count with differential and platelet count before initiating therapy 5, 3
  • Ongoing: Monthly CBC for prolonged therapy or prophylaxis to detect hematologic toxicity 4, 5, 3

Important Clinical Caveats

Formulation Considerations

  • For accurate dosing in younger children or those <40 kg, liquid formulation is preferred over tablets 5
  • Liquid suspension typically contains 40 mg trimethoprim + 200 mg sulfamethoxazole per 5 mL

Common Pitfalls to Avoid

  • Do not confuse the trimethoprim and sulfamethoxazole components when calculating doses—always base calculations on the trimethoprim component 4, 3
  • Do not use in G6PD deficiency due to risk of hemolytic anemia 3
  • Exercise caution with concurrent methotrexate as toxicity may increase 3

Serious Adverse Effects Requiring Discontinuation

  • Stevens-Johnson syndrome or toxic epidermal necrolysis 4
  • Severe blood dyscrasias 4
  • Hepatic necrosis 4
  • Life-threatening hypersensitivity reactions 5

Drug Interactions Requiring Monitoring

  • Anticoagulants (warfarin): increased bleeding risk 4, 3
  • Antidiabetic agents: enhanced hypoglycemic effect 4, 3
  • Anticonvulsants (phenytoin): altered levels 4, 3

References

Guideline

Pediatric Dosage of Sulfaprim (Trimethoprim/Sulfamethoxazole)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Bactrim Use in Pediatric Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Prophylaxis with Septran DS in Children

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.